[1]谷丽艳,易佳丽,樊延宏,等. 中医药疗法治疗乳腺增生研究进展[J].辽宁中医药大学学报,2014,16(1):173-176.
[2]Valerie C,Cathy S,Andrea Z,et al. PELP1 overexpression in the mouse mammary gland results in the development of hyperplasia and carcinoma[J].Cancer Res,2014,74(24):7395-7405.
[3]Liu J,Esmailpour T,Shang XY,et al.TBX3 over-expression causes mammary gland hyperplasia and increases mammary stem-like cells in an inducible transgenic mouse model[J].BMC Dev Biol,2011,11:65.
[4]章建民,陈宇,杨明艳,等. 乳腺增生兔模型的制备及初步评价消癖健乳巴布膏的药效[J]. 中华中医药学刊,2013,31(10):2166-2168.
[5]Tian J, Lambertz I, Thomas R, et al. Transgenic insulin-like growth factor-1 stimulates activation of COX-2 signaling in mammary glands[J]. Mol Carcinog, 2012, 51(12): 973-983.
[6]Wang CS, Sun B, Guo L. Volatile organic metabolites identify patients with breast cancer, cyclomastopathy, and mammary gland fibroma[J]. Sci Rep,2014, 4: 5383.
[7]虞昆,倪超,宋向阳,等. 乳腺癌组织中CD73表达及其与临床病理特征的相关性研究[J]. 中国临床药理学与治疗学,2017,22(5):551-555.
[8]Arendt LM, Kuperwasser C. Form and function: how estrogen and progesterone regulate the mammary epithelial hierarchy[J]. J Mammary Gland Biol Neoplasia,2015,20(1/2): 9-25.
[9]林中琳,董乃维.治疗乳腺癌小分子药物研究进展[J].中国临床药理学与治疗学,2015,20(8):956-960.
[10]Guo LY, Liu S, Jakulin A, et al. Positive expression of cyclin D1 is an indicator for the evaluation of the prognosis of breast cancer[J]. Int J Clin Exp Med,2015,8(10): 18656-18664.
[11]Howell A, Anderson AS, Clarke RB, et al. Risk determination and prevention of breast cancer[J]. Breast Cancer Res,2014,16(5): 446.
[12]夏丽娟,何云芹,邵明君. 左炔诺孕酮宫内节育系统治疗无排卵型功能失调性子宫出血的疗效[J].中国临床药理学与治疗学,2017,22(6):699-704.
[13]Zhang YN, Liu J, Lin J, et al. The transcription factor GATA1 and the histone methyltransferase SET7 interact to promote VEGF-mediated angiogenesis and tumor growth and predict clinical outcome of breast cancer[J]. Oncotarget, 2016,7(9): 9859-9875. |